Actually, the consolidation now is building a perfect chart appearance on CMRX too. When the market fully recognizes the value of this (CMRX) business, I'll be exiting but not before then.still accumulating for now. JMOpablo4, published June 4, 2020 Chimerix Inc. analyst estimates by MarketWatch. View CMRX revenue estimates and earnings estimates, as well as analyst recommendations. Chimerix Inc. insider activity by MarketWatch. View the latest news on CMRX company insiders for best stock investing positioning. Find out all the key statistics for Chimerix, Inc. (CMRX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Stock quote and company snapshot for CHIMERIX INC (CMRX), including profile, stock chart, recent news and events, analyst opinions, and research reports. StockTwits Read live tweets from the financial and investing community about the stock you're interested in. Chimerix (CMRX) Reports Q1 Loss, Lags Revenue Estimates: May 7: Recap: Chimerix Q1 Earnings: May 7: Chimerix EPS misses by $0.02, misses on revenue: May 7: Chimerix Reports First Quarter 2020 Financial Results and Provides Operational Update: May 2: One Thing To Remember About The Chimerix, Inc. (NASDAQ:CMRX) Share Price: Apr 30 Description: Chimerix Inc is a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases. The two clinical-stage development programs are dociparstat sodium (DSTAT) and brincidofovir (BCV).
Chimerix, Inc. CMRX 3.23 0.04 (1.25%). NASDAQ Updated Jun 8, 2020 8:00 PM
Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157. CMRX Chimerix, Inc. Stock Quote - FINVIZ.com Michael Sherman Is The CEO, President & Director of Chimerix, Inc. (NASDAQ:CMRX) And They Just Spent US$106k On Shares Simply Wall St. -15.89% Feb-28-20 12:00PM
CMRX | Complete Chimerix Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Chimerix, Inc. (CMRX) Valuation Measures & Financial ... Find out all the key statistics for Chimerix, Inc. (CMRX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Chimerix, Inc. (CMRX) Stock Forum & Discussion - Yahoo Finance Find the latest Chimerix, Inc. (CMRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Dave & Buster's Entertainment - Stocktwits
Catalyst Pharmaceutical Partners Inc. CPRX 4.53 0.05 (1.03%). NASDAQ Updated Jun 8, 2020 11:54 PM
Moleculin Biotech. MBRX 1.15 0.06 (5.51%). NASDAQ Updated Jun 9, 2020 8:08 AM RVP Retractable Technologies Inc. - Stocktwits Retractable Technologies Inc. RVP 5.97 0.05 (0.85%). NYSEMkt Updated Jun 8, 2020 8:00 PM
Dave & Buster's Entertainment. PLAY 21.55 2.66 (13.78%). NASDAQ Updated Jun 8, 2020 11:59 PM
Chimerix Inc. (NASDAQ: CMRX) stock closed at 3.3 per share at the end of the most recent trading day (a 1.85 % change compared to the prior day closing price) with a volume of 444.81K shares and market capitalization of 206.23M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 40 people. ETFs That Own CMRX | ETF Daily News StockTwits Twitter. Toggle navigation Toggle navigation. ETFs That Own CMRX. We found 17 ETFs that hold Chimerix, Inc. (CMRX). Symbol ETF Name CMRX: Chimerix Inc - Brokerage Reports - Zacks.com CMRX: Chimerix Inc broker reports. Get the latest broker reports from Zacks Investment Research. CMRX: Chimerix Inc - Cash Flow Statements - Zacks.com